Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04710628
Title Combination of Pembrolizumab and Lenvatinib, in Pre-treated Thymic CArcinoma paTIents (PECATI)
Acronym PECATI
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors MedSIR
Indications
Therapies
Age Groups: adult | senior
Covered Countries ITA | FRA | ESP

Facility Status City State Zip Country Details
Institut Bergonié Bordeaux France Details
Centre Oscar Lambert Lille France Details
Hôpitaux Universitaires de Marseille - Hôpital Nord Marseille France Details
Institut Curie Paris France Details
Centre Hospitalier Universitaire de Toulouse Toulouse France Details
IGR Gustave Roussy Villejuif France Details
A.O.U. San Luigi Gonzaga Orbassano Italy Details
Hospital Clinic i Provincial de Barcelona Barcelona 08036 Spain Details
Hospital Sant Creu i Sant Pau Barcelona Spain Details
Complejo Hospitalario Universitario A Coruña (CHUAC) La Coruña Spain Details
Hospital Universitario La Paz Madrid Spain Details
Hospital Universitario Virgen del Rocío Sevilla Spain Details
Hospital Universitari i Politècnic La Fe Valencia Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field